Targeted immunomodulation using antigen-conjugated nanoparticles.
about
Improving the clinical impact of biomaterials in cancer immunotherapy.Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine PlatformConvergence of nanotechnology and cancer prevention: are we there yet?Cellular and molecular targeting for nanotherapeutics in transplantation tolerance.Tolerogenic Nanoparticles to Treat Islet Autoimmunity.An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.
P2860
Targeted immunomodulation using antigen-conjugated nanoparticles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted immunomodulation using antigen-conjugated nanoparticles.
@en
Targeted immunomodulation using antigen-conjugated nanoparticles.
@nl
type
label
Targeted immunomodulation using antigen-conjugated nanoparticles.
@en
Targeted immunomodulation using antigen-conjugated nanoparticles.
@nl
prefLabel
Targeted immunomodulation using antigen-conjugated nanoparticles.
@en
Targeted immunomodulation using antigen-conjugated nanoparticles.
@nl
P2093
P2860
P356
P1476
Targeted immunomodulation using antigen-conjugated nanoparticles.
@en
P2093
Bryce Chackerian
Derrick P McCarthy
Lonnie D Shea
Stephen D Miller
Zoe N Hunter
P2860
P304
P356
10.1002/WNAN.1263
P577
2014-03-10T00:00:00Z